About Meiosis-specific protein MEI4
Meiosis-specific protein MEI4 (MEI4) is a protein
from Homo sapiens identified by UniProt accession
A8MW99, 385 residues long.
MolForge cross-references it against 0 known binders and
115 disease associations.
Target properties
| Protein name | Meiosis-specific protein MEI4 |
| UniProt accession | A8MW99 |
| Gene | MEI4 |
| Organism | Homo sapiens |
| Length | 385 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (115)
Diseases linked to this target (Open Targets).
- vertebral disorder · score 0.33
- mathematical ability · score 0.31
- adolescent idiopathic scoliosis · score 0.30
- tissue factor measurement · score 0.13
- azoospermia · score 0.08
- male infertility with teratozoospermia due to single gene mutation · score 0.07
- 46,XX testicular disorder of sex development · score 0.06
- partial chromosome Y deletion · score 0.06
- Testicular regression syndrome · score 0.06
- isolated congenital hypogonadotropic hypogonadism · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-A8MW99-F1 | alphafold | PREDICTED | 70.21 | — |
Amino-acid sequence (385 residues)
MDVQKWYLRT SKLALALAII RSKPADKSSR EYTEHLAMLL SEEQSKWRSK VEILEAEVMQ LRQKLLVSRL CSGSFKSGYV SSQLEAQEPK SSESTLTSME DSGCDLSNEQ RTESSDLSQH FVESCTPTHF PPLPLVKRPC AILQNPLSSH MQFLQYLLEL KNLTESGNLK RDLTHFEKDS STVSDSVFQL LDGLITFYRN PKLPFSRFWT EAVGTLASLI SDYNLSSHIL KKCSKKLEEF EKTLLHAILG NNHINQFQVQ HYVSQSLVTL GNCSLLRKSI ISLLLSEVNG FADDLGAINQ EQASYDVSRY ENIFYLFWVL EQLLQKETEE GNTSSIGHDD QEIKKFLQKH DETIFQLSDA FPLFTFYLWR VGILLSSAQI ETLRK
Explore Meiosis-specific protein MEI4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets